Cardiac metabolic imaging: current imaging modalities and future perspectives

Medical Imaging: Current status and future perspectives

Medical imaging is often thought of as a way of viewing anatomical structures of the body. Indeed, x-ray computed tomography and magnetic resonance imaging yield exquisitely detailed images of such structures. It is often useful, however, to acquire images of physiologic function rather than of anatomy. Such images can be acquired by imaging the decay of radioisotopes bound to molecules with kn...

Molecular-genetic imaging: current and future perspectives.

Current and Future Lymphatic Imaging Modalities for Tumor Staging

Tumor progression is supported by the lymphatic system which should be scanned efficiently for tumor staging as well as the enhanced therapeutic outcomes. Poor resolution and low sensitivity is a limitation of traditional lymphatic imaging modalities; thus new noninvasive approaches like nanocarriers, magnetic resonance imaging, positron-emission tomography, and quantum dots are advantageous. S...

Somatostatin Receptor Imaging: Current Status and Future Perspectives

The neuropeptide somatostatin—a cyclic tetradecapeptide first isolated from ovine hypothalamus (1)—is the most widely distributed of the hypothalamic releasing hormones in the central nervous system and in the periphery, including the pancreas, gut, and pituitary. In the brain, somatostatin is believed to function as a neurotransmitter and neuromodulator (2). The effect of somatostatin in the p...

Somatostatin receptor imaging: current status and future perspectives.

The neuropeptide somatostatin—a cyclic tetradecapeptide first isolated from ovine hypothalamus (1)—is the most widely distributed of the hypothalamic releasing hormones in the central nervous system and in the periphery, including the pancreas, gut, and pituitary. In the brain, somatostatin is believed to function as a neurotransmitter and neuromodulator (2). The effect of somatostatin in the p...